, Andrew J. Phillips 6 & Ruslan Medzhitov 1, 4, 8 Macrophages have an important role in the maintenance of tissue homeostasis 1 . To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition 2 . Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth [3] [4] [5] . However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1a (HIF1a). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.
To study tumour-macrophage interactions, we used syngeneic murine tumour models of Lewis lung carcinoma (LLC) and B16-F1 (B16) melanoma cancer cell lines. LLC and B16 cells were subcutaneously injected into C57BL/6J mice. At day 19, the tumours were harvested and analysed for the presence of macrophages. Histological analysis showed that, in both LLC and B16 tumours, F4/80 1 macrophages and CD11b 1 macrophages were present at a high density in the tumour periphery, as well as in cords and clusters throughout the interior of the tumours (Extended Data Fig. 1a, b) . Fluorescence-activated cell sorting (FACS) analysis showed that the F4/80 1
CD11b
1 macrophages constituted between 1% and 6% of all cells within the tumours. Although the extent of macrophage recruitment varied between the tumour types, it remained constant for tumours of each type (Extended Data Fig. 1c, d ). The sorted tumour-associated macrophages (TAMs) were vacuolated or foamy in appearance and thus morphologically distinct from peritoneal macrophages (Extended Data  Fig. 1e ). The TAMs expressed high levels of vascular endothelial growth factor (Vegf; also known as Vegfa) and arginase 1 (Arg1) messenger RNA compared with peritoneal macrophages (Fig. 1a, b) , and they expressed more Vegf and Arg1 mRNA than all of the other cells within the tumour combined. Thus, consistent with the current thinking 5 , tumour cells recruit macrophages and induce their functional polarization into TAMs.
We hypothesized that tumour-derived signals activate macrophages to reach a tumour-promoting state that is characterized by the expression of Arg1 and Vegf. The upregulation of Vegf and Arg1 in macrophages might support tumour growth by inducing neovascularization and by providing the substrates for cancer cell proliferation, respectively 5, 6 . Therefore, we used Vegf and Arg1 mRNA as read-outs to study the signals that tumours produce that promote the functional polarization of TAMs. The expression of Vegf has been characterized best in the context of hypoxia 7 , whereas Arg1 expression in macrophages has been best characterized in response to the T-helper-2-derived cytokines interleukin 4 (IL-4) and IL-13 (ref. 8 ). First, we tested whether Vegf and Arg1 induction in macrophages is mediated by a secreted tumour-derived signal. We incubated bone-marrow-derived macrophages with LLC-tumour-conditioned medium and measured Vegf and Arg1 expression in the macrophages. Tumourconditioned media induced both Vegf and Arg1 expression in bone-marrowderived macrophages under normoxic conditions (Fig. 2a, b) .
Vegf expression is induced by ischaemia, during which the loss of both oxygen and nutrients can induce Vegf through different pathways: hypoxia induces Vegf expression via the transcription factor HIF1a, while nutrient deprivation induces Vegf expression through the transcriptional co-activator PGC1a (peroxisome-proliferator-activated receptor c, coactivator 1a) 9 . We found that a tumour-derived signal(s) induces Vegf expression in macrophages under normoxic conditions by the same pathway through which hypoxia induces Vegf expression: that is, stabilization of HIF1a. Macrophages stimulated by tumour-conditioned media had stabilized HIF1a protein under normoxic conditions (Extended Data Fig. 2a) . Furthermore, using luciferase reporter assays that determined both the stability of the HIF1a protein's oxygen-dependent domain and the activity of the Vegf promoter, we found that tumour-conditioned media stabilized HIF1a and induced the Vegf promoter under normoxic conditions to a level similar to that induced by hypoxia (Extended Data  Fig. 2b, c) . In addition to HIF1a protein stabilization, tumour-conditioned media induced the expression of the inducible isoform of the HIF1A gene (HIF1A I.1) but not the constitutive isoform (HIF1A I.2). Neither the Pgc1a nor Pgc1b co-activator, which are associated with the induction of Vegf during nutrient deprivation, was induced by tumour-conditioned media (Extended Data Fig. 2d, e) . To determine whether HIF1a is critical for tumour-induced upregulation of Vegf and Arg1 expression, we used Hif1a fl/fl 3 Lysm cre/wt mice, in which HIF1a is specifically deleted in myeloid cells. In the resultant Hif1a 2/2 macrophages, neither Vegf nor Arg1 was induced by either hypoxia or tumour-conditioned media (Fig. 2c-f) . Together, these findings indicate that a tumour-derived soluble factor(s) induce Vegf and Arg1 in macrophages via HIF1a under normoxic conditions.
After determining that the tumours induced Vegf and Arg1 expression via HIF1a, we next sought to identify the tumour-derived soluble factor capable of activating HIF1a under normoxic conditions. The tumourconditioned medium was fractionated by size (,3 kDa and .3 kDa), and the activity of both fractions was tested. Both unfractionated tumourconditioned medium and the ,3 kDa fraction stabilized HIF1a and upregulated Arg1 expression ( Fig. 3a and Extended Data Fig. 2f) ; the .3 kDa fraction had none of these effects. Furthermore, the ,3 kDa fraction strongly upregulated Arg1 and Vegf expression ( Fig. 3b and Extended Data Fig. 2g ). Its activity was also heat stable: that is, it induced Arg1 and Vegf after prolonged boiling (Extended Data Fig. 2h ).
At least four soluble factors of ,3 kDa are known to stabilize HIF1a under normoxic conditions: adenosine, acidic pH, pyruvate and lactate [10] [11] [12] . Acidic pH was not able to stabilize HIF1a in macrophages under normoxic conditions, and an inhibitor of adenosine did not abrogate the induction of Vegf by tumour-conditioned medium (Extended Data Fig. 2i, j) . We therefore focused on the possibility that tumour-derived lactate is the soluble factor responsible for the polarization of TAMs. Warburg observed that cancer cells preferentially perform aerobic glycolysis: that is, they convert most glucose molecules into lactate regardless of the amount of oxygen present 13 . Furthermore, the eponymous Warburg effect is also observed in most cells undergoing rapid proliferation 14 . It has been hypothesized that aerobic glycolysis is conducive to cell proliferation because, despite the consequent reduction in ATP production, aerobic glycolysis produces metabolic precursors, such as lactate, for biosynthetic pathways, and these precursors may be the limiting factor during rapid cell proliferation 14 . One of the key enzymes involved in aerobic glycolysis is pyruvate kinase, which catalyses the production of pyruvate from its precursor during glycolysis. Specifically, the M2 isoform-but not the M1 isoform-of pyruvate kinase is preferentially active during aerobic glycolysis 15 . When cells expressing the M2 isoform were compared with cells expressing the M1 isoform for differences in the intracellular metabolites that they produced, the levels of lactate and pyruvate produced proved to be the most different. We investigated the differential expression of the M1 (Pkm1) and M2 (Pkm2) isoforms in different tumour cell lines and normal tissues. As expected, whereas PKM1 was the predominant isoform in differentiated tissues, particularly in metabolically active brown adipose tissue, muscle and heart, Pkm2 was the predominant isoform in a variety of tumour cell lines (Extended Data Fig. 3a-c) .
We next measured the levels of lactic acid in the media from a variety of tumour cell lines. Interestingly, LLC and B16 cells-the most malignant tumour lines tested-yielded the highest concentrations of lactate (Fig. 3c) , suggesting that the Pkm2 expression level and the subsequent lactate production correlate with tumour malignancy. When macrophages were then stimulated with these tumour-conditioned media, the magnitude of Vegf induction correlated with the amount of lactate that accumulated in the media (Fig. 3d) .
When the tumour-conditioned media were fractionated, the vast majority of the lactate partitioned into the ,3 kDa fraction (Extended Data  Fig. 3d ). Furthermore, lactic acid alone was sufficient to induce Vegf and Arg1 expression in macrophages in a dose-dependent manner (Fig. 3e, f) . Using mass spectroscopy for quantitation, we determined that the in vivo intratumoral lactate levels were equivalent to the lactate concentrations required for in vitro induction of Vegf and Arg1 (Extended Data Fig. 3e ). When macrophages were stimulated with either lactic acid or hypoxia (0.1% O 2 ), the induction of Vegf expression peaked at 6 h post stimulation, whereas Arg1 induction peaked at 24 h post stimulation (Extended Data Figs 4 and 5) . The cellular uptake of lactic acid, mediated by monocarboxylate transporters (MCT1, MCT2, MCT3 and MCT4), is necessary for the induction of Vegf, as indicated by the abrogation of Vegf induction in macrophages by LLC-conditioned media after exposure to a-cyano-4-hydroxycinnamate, an MCT inhibitor (Extended Data Fig. 6a) . Furthermore, as monocarboxylate transporters are proton-coupled symporters, the induction of Vegf by lactate was dependent on an acidic pH (Extended Data Fig. 6b ). Although lactic acid was sufficient to induce Vegf in LLC and B16 tumour cells (Extended Data Fig. 6c ), the relative levels of expression observed in vivo are greatest in TAMs (Fig. 1a) .
Finally, similarly to the induction of Vegf and Arg1 by hypoxia, the induction of these genes by tumour-conditioned media and lactic acid Relative expression , displayed as mean 6 s.e.m. *P , 0.01, using a two-tailed, unpaired t-test. All experiments were performed at least twice.
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was also dependent on HIF1a, as HIF1a-deficient macrophages were not able to upregulate Vegf or Arg1 on stimulation with lactic acid (Fig. 3g, h ). Collectively, these findings suggest a model in which macrophages are recruited to the tumour micro-environment, where tumour-derived lactic acid induces HIF1a-dependent polarization of macrophages, including the induction of Vegf and Arg1.
To determine whether lactic acid can induce an M2-like phenotype in TAMs, FACS sorting of F4/80 1
CD11b
1 macrophages was performed on syngeneic LLC tumours at day 19 after injection. Gene expression analysis revealed that these TAMs have an M2-like profile, with the expression of Fizz1, Mgl1 and Mgl2 at levels higher than in all other tumour cells combined (Fig. 4a) . Compared with F4/80 1
1 FACSsorted peritoneal macrophages, TAMs express higher levels of the M2-associated genes Arg1 and Mrc1 but not higher levels of Ym1, Mgl1, Mgl2 or Fizz1 (Extended Data Fig. 7 ). Since lactic acid is sufficient to induce Arg1 in macrophages, we asked whether the expression of other M2 markers is induced by lactic acid. We found that lactic acid was sufficient to induce the M2 markers Fizz1, Mgl1 and Mgl2 in bone-marrowderived macrophages ( Fig. 4b and Extended Data Fig. 8a ). Given that HIF1a is required for the induction of Arg1 by lactic acid in vitro, we asked whether HIF1a is required for the induction of other M2 markers in vivo. TAMs from LLC tumours injected into wild-type mice and mice with HIF1a-deficient macrophages were sorted by FACS, and their expression of M2 markers was compared. Arg1, Fizz1, Mgl1 and Mgl2 were all expressed at lower levels in TAMs from mice with HIF1a-deficient macrophages than from wild-type mice ( Fig. 4c and Extended Data Fig. 8b ).
IL-4 and IL-13 are the best-characterized inducers of M2 polarization of macrophages 8 , but the downstream steps involved in M2 polarization are poorly defined 16 . To determine whether HIF1a is required for IL-4-induced M2 polarization, macrophages from HIF1a-deficient and wild-type mice were stimulated with IL-4, and their gene expression was compared. The induction of Arg1, Fizz1 and Mgl2 was significantly impaired in HIF1a-deficient macrophages compared with wild-type macrophages (Fig. 4d) . By contrast, the induction of Mgl1 was intact, suggesting that HIF1a is required for a subset of M2-associated genes, whether stimulated by lactic acid, hypoxia or IL-4. To determine whether IL-4 and IL-13 signalling is required for the M2 polarization of LLC TAMs in vivo, we isolated TAMs from mice deficient in the IL-4 receptor a-chain (IL-4Ra), a component of the receptors for both IL-4 and IL-13, and compared their gene expression with that of TAMs from wild-type mice. The levels of Arg1 mRNA were higher in TAMs from IL-4Ra-deficient mice than from wild-type mice, and the other M2 markers were present at only moderately lower levels than in wild-type mice. Therefore, IL-4 and IL-13 signalling are not critical for the TAM M2-like phenotype in this model (Fig. 4e) . Together, these findings suggest that there is an alternative pathway to an M2-like state that does not require IL-4 and IL-13 but is instead mediated by HIF1a. In addition, these results demonstrate that the induction of at least some M2-associated genes by IL-4 is dependent on HIF1a.
To determine whether lactic acid is driving macrophage polarization in vivo, we generated stable LLC tumour cell lines in which Pkm2 was knocked down and then injected these cells subcutaneously into wild-type mice. The Pkm2-knockdown tumours had a lower in vivo concentration of lactic acid than tumours bearing scrambled constructs. Furthermore, TAMs isolated from the Pkm2-knockdown tumours contained approximately half of the amount of Arg1 mRNA, and the tumours were significantly smaller (Fig. 4f) . Although interpretation of this result is complicated by the probable cell-intrinsic effect of Pkm2 knockdown, this finding is at least consistent with the model in which PKM2-dependent lactic acid production by tumour cells has an important role in TAM polarization. As a converse correlate to these experiments, to determine whether lactic acid stimulation of bone-marrow-derived macrophages ex vivo confers a growth advantage on LLC tumours, we compared the tumour volumes in mice co-injected with LLC cells plus control-mediumstimulated bone-marrow-derived macrophages and in mice co-injected with LLC cells plus lactic-acid-stimulated bone-marrow-derived macrophages. Co-injection of the lactic-acid-stimulated bone-marrow-derived macrophages resulted in significantly larger tumours than did co-injection of the control-medium-stimulated bone-marrow-derived macrophages (Extended Data Fig. 9a ). To determine whether lactic acid is used as a metabolic substrate, as well as a polarizing signal, in TAMs, we measured the oxidation of 14 C-lactic acid. TAMs oxidized more 14 C-lactic acid to 14 CO 2 than either bone-marrow-derived macrophages or cultured LLC cells (Extended Data Fig. 9b ), suggesting that TAM polarization allows increased utilization of lactic acid. e, f, Expression analysis by qPCR of Vegf (e) and Arg1 (f) mRNA in bonemarrow-derived macrophages cultured with a concentration gradient of lactic acid (LA). g, h, Expression analysis by qPCR of Vegf and Arg1 mRNA in wild-type (WT) and Hif1a 2/2 bone-marrow-derived macrophages. b-h, The histogram bars represent the expression level of three biological replicates (relative to expression in DMEM), displayed as mean 6 s.e.m. *P , 0.0001; **P , 0.001, using a two-tailed, unpaired t-test. All experiments were performed at least twice. NS, not significant; RLA, relative luciferase activity.
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The role of VEGF in promoting neovascularization and subsequent growth of tumours is well established 17 . However, the role of macrophagederived ARG1 is unclear, despite being part of the signature of the TAM phenotype. ARG1 is known to be involved in a pathway that generates polyamines, which are essential metabolites during cell division and have been shown to regulate tumour cell proliferation in vitro 6 . ARG1 is also one of five urea cycle enzymes that is important in nitrogen metabolism. Therefore, we sought to determine whether macrophage-derived ARG1 is involved in tumour progression by using a syngeneic tumour model in Arg1 fl/fl 3 Lysm cre/wt mice, whose macrophages are deficient in ARG1. Tumours from ARG1-deficient mice were approximately half the size of those from wild-type mice, indicating that macrophage-derived ARG1 has an important role in tumour progression ( Fig. 4g and Extended Data Fig. 9c, d ).
Together, these findings demonstrate that lactate, a by-product of glycolysis, induces TAM polarization characterized by the induction of Vegf expression and differentiation into an M2-like phenotype. Pioneering studies by Folkman demonstrated the crucial role of neovascularization in tumour growth 18 . It has generally been assumed that cancer cells experiencing hypoxia in a growing tumour are themselves the source of VEGF. However, our findings suggest that, at least in some cases, it is the tumour accessory cells, including macrophages, that are the main source of VEGF. It should be noted that the elimination of one source of VEGF will probably result in compensatory VEGF production by alternative cellular sources 5 . Further studies will be necessary to elucidate the specific tumour features that dictate the primary source of VEGF.
ARG1 is widely accepted as a marker of M2 macrophages, but the functional role of ARG1 in M2 macrophages has been determined only in the context of helminth infection 19 . Our findings suggest that Arg1 expression in TAMs has an important role in tumour growth, possibly via an ARG1-dependent pathway responsible for producing polyamines, which are substrates that have a critical role in cell proliferation. In addition, TAMs may contribute to nitrogen metabolism in the tumour microenvironment, as all five enzymes of the urea cycle are expressed at higher levels in TAMs than in all other tumour cells (Extended Data Fig. 10 ). TAMs also express higher levels of the transaminase Gpt and of glutamine synthetase (Glul), which also facilitate nitrogen metabolism, than all other tumour cells.
We observed that the effect of lactate on tumour cell proliferation is mediated by HIF1a and, interestingly, is independent of IL-4Ra signalling. However, in other tumour models, IL-4 produced by T helper 2 cells has an important role in the M2 polarization of TAMs 20 . Thus, multiple pathways for the induction of the M2 phenotype in TAMs probably exist, and further investigation is necessary to characterize the features of tumour cells or their tissue environment that dictate the induction of the M2 phenotype.
In conclusion, we found that tumour-cell-derived lactic acid has an important signalling role in the induction of several key features of TAM polarization and the subsequent promotion of tumour growth. Lactic acid, as a by-product of aerobic glycolysis, can be a 'reporter' of cell proliferation. Lactic acid is also a by-product of anaerobic glycolysis, which in metazoan cells is typically indicative of hypoxia. These features of lactic acid may explain its ability to induce Vegf, Arg1 and other M2-associated genes in TAMs. Finally, we expect that multiple signals are involved in
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Relative expression TAM  AO  TAM  AO  TAM  AO  TAM  AO  TAM  AO  TAM  AO  TAM  AO  TAM 2/2 macrophages (e). f, Intratumoral lactic acid concentrations (mM) from tumours of LLC cells that had been stably transfected with a scrambled short hairpin RNA (shRNA) construct (SCR) or an shRNA targeting Pkm2 (centre panel). Expression analysis by qPCR of Arg1 mRNA in TAMs isolated from SCR-transfected and Pkm2-knockdown tumours. Weight of LLC tumours from cells bearing an SCR construct (mean 6 s.e.m., 2.402 6 0.310 g; n 5 5) or Pkm2 shRNA construct (mean 6 s.e.m., 0.8820 6 0.341 g; n 5 4); P 5 0.0132 using a two-tailed, unpaired t-test (right panel). The F test revealed no significant difference in variance between the compared groups. g, Weight of LLC tumours resected on day 19 from mice with WT macrophages (mean 6 s.e.m., 1.74 6 0.161 g; n 5 11) or ARG1-deficient macrophages (mean 6 s.e.m., 0.965 6 0.163 g; n 5 13); P , 0.0028 using a two-tailed, unpaired t-test. The F test revealed no significant difference in variance between the compared groups. a-f, The histogram bars represent the expression level of three biological replicates, displayed as mean 6 s.e.m., relative to AO (a, c, e, f) or DMEM (b, d). *P , 0.05; **P , 0.001, using a two-tailed, unpaired t-test. All experiments were performed at least twice. NS, not significant.
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the communication between tumour cells and macrophages. Indeed, recent findings demonstrate the important role of tumour-cell-derived versican 21 and macrophage colony-stimulating factor 22 in tumourmacrophage communication. These and other, yet to be discovered, signals involved in macrophage polarization are presumably not specific to tumours. That is, as tumours represent an abnormal and exaggerated version of normal tissue growth, the role of TAMs reflects the role of macrophages in normal tissue maintenance and repair.
METHODS SUMMARY
Syngeneic tumour model. LLC (LL/2), B16-F1 melanoma or CT.26WT colon carcinoma cells were injected subcutaneously into the flanks of mice (1 3 10 6 , in 200 ml PBS). Both male and female C57BL/6J (LLC and B16) and BALB/c (CT26) strains of mice (Jackson Laboratory) were used. Mice were 6 to 8 weeks of age. The resultant tumours were resected and transferred to PBS on ice. Tumour weight (g) was measured on a scale after transferring the specimen to a sterile Petri dish. The tumours from all experiments were then processed for FACS analysis or sorting (see Methods) on the same day or fixed in formalin for immunohistochemistry. Tumour supernatant preparation and collection. Cell lines were grown in DMEM plus supplements (DMEM-complete; containing 10% FBS, 1% penicillin and streptomycin, 1% HEPES, 1% L-glutamine and 1% sodium pyruvate). Fractionation of LLC tumour supernatants was achieved using Amicon Ultra centrifugal filters (3K Ultracel, Millipore). The supernatant fraction .3 kDa remained above the filter, and the fraction ,3 kDa passed through to the lower chamber. The .3-kDa fraction was resuspended in unsupplemented DMEM to the pre-filtration volume. Determination of lactate concentration. The lactate concentration was measured using a Lactate Assay Kit (BioVision) according to the manufacturer's instructions.
The mean values and s.e.m. of the lactate concentration were calculated for each condition. The mean intratumoral lactic acid concentration was determined for LLC and B16 tumours after homogenization (Polytron) and methanol extraction, using hydrophilic interaction chromatography and mass spectroscopy, as well as the colorimetric lactate assay.
METHODS
Materials. The anti-ARG1 antibody for western blotting was purchased from BD Transduction Laboratories (catalogue number, 610708). Rabbit anti-HIF-1a antibody was purchased from Novus Biologicals (catalogue number, NB100-449; lot A4). Anti-CD31 antibody for immunohistochemistry was purchased from Abcam (catalogue number, ab28364). Liberase TM Research Grade was purchased from Roche. ACK lysing buffer was purchased from BioWhittaker (Lonza). RLT buffer (lysis buffer) was purchased from QIAGEN (mat. no. 1015762). The Lactate Assay Kit was purchased from BioVision (catalogue number, K607-100). The SMARTer PCR cDNA Synthesis Kit was purchased from Clontech. PerfeCTa SYBR Green SuperMix was purchased from Quanta BioSciences (Lot 14699). RNA Bee was purchased from amsbio. Lactic acid was purchased from Sigma ($98% purity; catalogue number, L6402-1G). DNase I was purchased from Sigma. The HIF1a reporter was obtained from Addgene (plasmid 18965, ODD-Luciferase-pcDNA3). Primers. The following primers were used to determine the relative gene expression using quantitative PCR (qPCR). Short hairpin RNA constructs. The following short hairpin RNA (shRNA) constructs, cloned into the pGFP-V-RS plasmid, were obtained from OriGene and used for transfection: TR30013 (scrambled control used in Fig. 4f ), 59-GCACTACCAG AGCTAACTCAGATAGTACT-39; HT122914B (Pkm2 knockdown 1 used in Fig. 4f ), 59-GCCTCCTTCAAGTGCTGCA-39; and HT122915A (Pkm2 knockdown 2), 59-CAGCTATTCGAGGAACTCC-39. Mice. Lysm cre/wt and Arg1 fl/fl mice were purchased from the Jackson Laboratory and bred in our facility. C57BL/6J and BALB/c mice were purchased from the National Cancer Institute. Macrophage-specific ARG1-deficient mice were generated by crossing Lysm cre/wt and Arg1 fl/fl mice. Lysm wt/wt 3 Arg1 fl/fl mice were used as controls. All mice used were on a C57BL/6J background. Hif1a fl/fl mice were purchased from the Jackson Laboratory. Macrophage-specific HIF1a-deficient mice were created by crossing Lysm cre/wt and Hif1a fl/fl mice. Lysm wt/wt 3 Hif1a fl/fl mice were used as controls. Il4ra 2/2 mice were provided by K. Bottomly. All animal experiments were performed in accordance with the guidelines of Yale University's Institutional Animal Care and Use Committee. Syngeneic tumour model. LLC, B16-F1 melanoma (B16) or CT.26WT colon carcinoma (CT26) cells (1 3 10 6 , in 200 ml PBS) were injected subcutaneously into the flanks of mice. Both male and female C57BL/6J (LLC and B16) and BALB/c (CT26) strains of mice were used. Mice were 6 to 8 weeks of age. There was no systematic means of randomization of mice. Three-digit codes identified the mice, and the experiment was carried out blindly throughout. The mice were killed on day 19. Tumours were resected and transferred to 5 ml PBS on ice. Tumour weight (g) was measured on a scale by transferring the specimen to a sterile Petri dish after removal of surface moisture with Kimwipes. The tumours from all experiments were then processed for FACS analysis or sorting on the same day or fixed in formalin for immunohistochemistry. For co-injection experiments, 1 3 10 6 bone-marrow-derived macrophages (BMDMs) were plated in 1 ml macrophage-growth medium (MGM) in 12-well non-tissue culture plates and stimulated with 1 ml 50 mM lactic acid in DMEM (final concentration, 25 mM lactic acid) or unsupplemented DMEM for 24 h. LLC cells (1 3 10 6 ) were combined with 1 3 10 6 control or lactic-acid-stimulated BMDMs, resuspended in 200 ml PBS and co-injected subcutaneously. Mice that developed ulcers overlying the tumours were killed according to the guidelines of Yale University's Institutional Animal Care and Use Committee protocol. There were no exclusion criteria for the tumours. Preparation of single cell suspensions from tumours. The resected mouse tumours were mechanically dissociated with surgical scissors and digested with 2 U Liberase TM and DNase I in PBS for 30 min in a 37 uC shaking incubator (150 r.p.m.). After enzymatic dissociation, the samples were transferred to ice to stop the reaction. The tumour suspension was then strained using a 70 mm cell strainer (Becton Dickinson) and washed with FACS buffer (0.5% FBS in PBS) and centrifuged at 1,300 r.p.m. at 4 uC (similar centrifugation parameters were used throughout). Red blood cells were lysed with ACK lysing buffer followed by washing with FACS buffer. The samples were then resuspended in FACS buffer. The samples were kept on ice throughout the rest of the staining process. FACS of TAMs. Anti-mouse CD16/32 antibody (eBioscience) was added to the samples at a 1:200 dilution for 20 min at 4 uC to block non-specific Fc receptor binding. Samples were then washed with FACS buffer and stained with anti-CD11b-PerCP antibody (eBioscience; clone, M1/70; catalogue number, 45-0112-82; used at 1:100) and anti-F4/80-APC antibody (eBioscience; clone, BM8; catalogue number, 17-4801-82; used at 1:100) at 4 uC for 15 min in the dark. The samples were then washed twice and resuspended in FACS buffer for sorting. The samples were sorted on a MoFlo cell sorter (Beckman Coulter) equipped with Summit software. Photomultiplier tube (PMT) voltages were set with the unstained tumour cell suspension, and compensations were performed with single colour controls. For sorting, live cells were initially selected on the basis of forward scatter (FSC) and side scatter (SSC), followed by gating on singlets to ensure that individual cells were obtained. Next, the CD11b-PerCP and F4/80-APC double-positive population was selected and sorted. Other cells, negative for CD11b and F4/80, were also sorted simultaneously. An aliquot of sorted cells was removed for preparation of a Cytospin. The sorted cells were kept on ice and immediately resuspended in RLT buffer. Samples were then stored at 280 uC for subsequent gene expression analysis. Histological characterization of sorted TAMs. The cellular morphology of the sorted macrophages was analysed by Cytospin followed by haematoxylin and eosin staining. After sorting TAMs, 100 ml single cell suspension was transferred to Cytospin funnels and centrifuged in a Cytospin Cytocentrifuge (Thermo Scientific) for 5 min at 800 r.p.m. The slides were then stained with a Diff-Quik kit (Baxter Merz & Dade). Haematoxylin and eosin stained slides of sorted cells were visualized with an Optiphot Nikon microscope with a camera. Immunohistochemistry. Resected tumours were fixed in formalin, embedded in paraffin, sectioned and stained with haematoxylin and eosin. Immunohistochemistry with an anti-F4/80 antibody (eBioscience, clone BM8) and an anti-CD11b antibody (eBioscience, clone M1/70) was performed by the Yale Dermatopathology Laboratory. Tumour supernatant preparation and collection. Conditioned media (tumour supernatants) from the following American Type Culture Collection cell lines were prepared: B16, LLC (LL/2), CT-26 (CT26.WT, colon carcinoma), Hepa (Hepa 1-6, hepatoma) and NMuMG (normal murine mammary gland). All cell lines tested negative for Mycoplasma and Acholeplasma using the Venor GeM Mycoplasma Detection Kit (Sigma-Aldrich, catalogue number, MP0025). Each cell line was grown in DMEM-complete (containing 10% FBS, 1% penicillin and streptomycin, 1% HEPES, 1% L-glutamine and 1% sodium pyruvate) in 75 cm 2 BD Falcon flasks at 37 uC. When the cells reached 70% confluence, the DMEM-complete medium was aspirated, and the cells were rinsed with 10 ml Dulbecco's PBS (Sigma-Aldrich) and incubated with 3 ml 0.05% trypsin-EDTA (Gibco) for 5 min. To inhibit the trypsin reaction, DMEM-complete (7 ml) was added and mixed completely. Each cell suspension was counted with a haemocytometer and plated into three 25 cm 2 BD Falcon flasks (6 3 10 6 cells in 9 ml medium). Supernatants were collected on days 1, 2, 3 and 4. Conditioned medium from each of the flasks was transferred to a 15 ml BD Falcon tube and centrifuged at 1,300 r.p.m. for 10 min. The supernatant was sterile filtered using a 22 mm filter (Millex-GV) with a 10 ml syringe barrel. The samples were stored at 220 uC for future experiments. Fractionation of the LLC tumour supernatants was achieved using Amicon Ultra centrifugal filters (3K Ultracel, Millipore). The supernatant was centrifuged at 4,000 r.p.m. for 1 h. The supernatant fraction that was .3 kDa remained above the filter and that which was ,3 kDa passed through to the lower chamber. The .3-kDa fraction was resuspended in unsupplemented DMEM to the pre-filtration volume. Determination of lactate concentration. Lactate concentration was measured using a Lactate Assay Kit (BioVision) as per the manufacturer's instructions (catalogue number, K607-100). Conditioned tumour media (from NMuMG, Hepa, CT26, B16 and LLC cells) were diluted 1:400 with lactate assay buffer and prepared as quadruplicates for the colorimetric lactate assay. The absorbance was measured at 570 nm using a SpectraMax M5 microplate reader (Molecular Devices) immediately after sample preparation. Background absorbance was subtracted. The mean values for lactate concentration (mM) and the s.e.m. were calculated for each condition. The mean intratumoral lactic acid concentration was determined for the LLC
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and B16 tumours after homogenization (Polytron) and methanol extraction, using hydrophilic interaction chromatography and mass spectroscopy, as well as the colorimetric assay described above. Isolation of BMDMs. To prepare BMDMs, mice were killed (CO 2 gas for 60 s) and disinfected with 70% ethanol. A long midline abdominal incision was made, starting at the ventral abdomen and extending inferiorly to the coccyx. Additional vertical incisions were made on each leg, to separate the skin completely from the underlying muscle layer. Both lower extremities were excised, and the muscular layers were gently removed. The long bones, femur and tibia were then placed in RPMI medium (Sigma). To extract BMDMs, the long bones and medium were placed into a clean, dry mortar. The RPMI was then aspirated. The long bones were cleansed with ethanol for no more than 30 s, and the ethanol was removed by aspiration. The bones were then washed three times with RPMI. Fresh RPMI (10 ml) was added, and a mortar was used to pulverize the long bones. A 70 mm nylon BD Falcon cell strainer was placed atop a 50 ml BD Falcon tube, and the suspension was filtered into the 50 ml tube. To grind the long bones for a second time, RPMI (10 ml) was added to the mortar, and this suspension was filtered as before. This step was repeated for a third time. The resultant suspension was centrifuged at 1,200 r.p.m. for 5 min. The supernatant was then aspirated. ACK lysing buffer (2 ml) was then added, and the contents were incubated for 5 min at 21 uC. To stop the lysis reaction, 20 ml RPMI was added. The contents were then centrifuged. The supernatant was aspirated, and the resultant cell pellet was resuspended in 20 ml MGM. The cells were then plated at 3 3 10 7 cells in 20 ml Falcon Petri dishes (150 mm 3 15 mm). On day 4, 20 ml MGM was added. Preparation of peritoneal macrophages. Peritoneal macrophages were harvested by peritoneal lavage. Cold PBS was injected into the peritoneal cavity and extracted after gentle agitation. The peritoneal cell suspension was centrifuged at 1,300 r.p.m., and the cell pellet was mixed with 2 ml ACK lysing buffer. After centrifugation, cells were then resuspended in DMEM-complete and used for further experiments. In vitro stimulation of BMDMs and peritoneal macrophages. BMDMs were plated at 1 3 10 6 cells per well in a sterile six-well tissue culture plate in 1 ml MGM. The BMDM stimulation experiments included the following conditions: DMEMcomplete (1 ml, negative control), 50 mM lactic acid in DMEM-complete (1 ml, 25 mM final concentration), LLC supernatant (1 ml) and 20 ng ml 21 IL-4 in DMEM-complete (1 ml, 10 ng ml 21 final concentration). For normoxic experiments, the BMDMs were incubated at 37 uC in a humidified tissue culture incubator (5% CO 2 ). For hypoxic experiments, the BMDMs were plated in 1 ml DMEM-complete and incubated in an Autoflow NU-8500 incubator (0.1% O 2 and 5% CO 2 ) (Nuaire). The cells were harvested at 6 h and 24 h. The cells were used in subsequent experiments for qPCR and western blotting. The peritoneal macrophages were plated in DMEM-complete and prepared in the same way for in vitro stimulation studies as the BMDMs. Gene expression analysis. RNA was extracted from cells using RNA Bee according to the manufacturer's protocol. The RNA concentration was measured by using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific). cDNA was synthesized using a SMARTer PCR cDNA Synthesis Kit, in accordance with the manufacturer's protocol. qPCR reactions were performed with 0.25 mM each respective primer, 3 ml 1:10 dilution of cDNA and 6 ml PerfeCTa SYBR Green SuperMix in a total volume of 12 ml. qPCR was performed on an Mx3000P Thermocycler (Stratagene), and Rpl13a and Actb were used as housekeeping genes. The primers used in our gene expression experiments are shown in the Primers subsection above. Gene expression data were analysed by calculation of threshold values (Ct) and fold changes relative to an internal control. Oxidation of lactic acid. TAMs (1 3 10   6 ), all other tumour cells, BMDMs and LLC cells were cultured for 2 h in DMEM containing 100 mCi 
